polatuzumab vedotina
SpainDrugs containing this active substance
-
It is used to treat previously untreated diffuse large B-cell lymphoma, or to treat this same type of cancer when it has recurred or has not improved after at least one previous treatment and the patient is not eligible for a stem cell transplant.
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 140 mg Manufacturer: Roche Registration Gmbh
-
It is used to treat previously untreated diffuse large B-cell lymphoma, or to treat lymphoma that has recurred or has not improved after at least one previous treatment, and in cases where a stem cell transplant cannot be performed.
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 30 mg Manufacturer: Roche Registration Gmbh